Indefinite Delivery Contract 36E79725D0039

Award Date 9/23/25
Last Date to Order 9/22/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award indefinite delivery contract awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Concordia Pharmaceuticals Inc. for the procurement of Hydroxychloroquine SO4 200mg tablets. The contract has a total ceiling value of $20,293,080.60 and a period of performance from September 23, 2020 to September 22, 2025, with an initial one-year base period and four one-year option periods. The contract aims to provide an...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a total ceiling value of $10,219,342.40 and a period of performance extending to October 17, 2027. The contract is intended to establish a national supply source for various strengths of Hydrochlorothiazide (HCTZ) tablets, which are essential...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service. The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Avkare LLC, a pharmaceutical and medical supply company, to provide a wide range of pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a total ceiling value of $12,991,472.85 and a period of performance from March 16, 2020 to March 15, 2025. It was awarded as a...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products. The contract has a ceiling value of $8,612,710.75 and covers the supply of mycophenolic acid tablets in 180mg and 360mg strengths to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). This single-award IDC has...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Bryant Ranch Prepack, a for-profit small business manufacturer of pharmaceutical goods. The $250,000 multiple-award contract covers the supply of various prescription medications, including sevelamer carbonate 800mg tablets and Sumatriptan 6mg/0.5mL injection syringes, to support VA healthcare operations. The contract has a base period of one year from May 1, 2019, with...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned for-profit pharmaceutical manufacturer. The $29.25 million single-award IDC, which does not have a set-aside, will provide a national supply source for a variety of hydrocodone-acetaminophen tablet products in 100 and 500 count bottles to support Department of Defense, Department of Veterans Affairs, Indian...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
The federal Indefinite Delivery Contract (IDC) award was made to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in California. The IDC has a ceiling value of $4,547,341.50 and an ultimate completion date of May 23, 2026. The contract vehicle was awarded on May 24, 2021 by the Defense Logistics Agency, a defense agency, and is not set-aside for any particular business category. The IDC primarily covers the manufacture and distribution of a...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC, with a ceiling value of $8,346,790.65, is for the supply of clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a 5-year period from March 2023 to March 2026. The contract was competitively...

This federal Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Bryant Ranch Prepack, a for-profit manufacturer of pharmaceutical goods. The single-award, unrestricted contract has a ceiling value of $14,563,769.10 and covers the supply of Hydroxychloroquine SO4 200MG tablets in 100-tablet and 500-tablet packages to support the procurement needs of the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).

The contract has a base period of one year from September 23, 2025 to September 22, 2026, with four additional one-year option periods. Deliveries will be made through the VA and DoD Pharmaceutical Prime Vendor Programs. The original solicitation, numbered 36E79725R0022, was issued under NAICS code 325412 for Pharmaceutical Preparation Manufacturing. The procurement aims to ensure an uninterrupted supply of the specified pharmaceutical product to various federal healthcare agencies and systems.

Generated 7/16/25, 12:20 PM